This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1990;9(1):20-33.

doi: 10.1007/BF02918476.

A family of trans-acting factors with distinct regulatory functions control expression of MHC class II genes

R S Accolla¹, P Dellabona, L Scarpellino, G Carra, S Sartoris

Affiliations

PMID: 2406350
DOI: 10.1007/BF02918476

Review

A family of trans-acting factors with distinct regulatory functions control expression of MHC class II genes

R S Accolla et al. Immunol Res. 1990.

. 1990;9(1):20-33.

doi: 10.1007/BF02918476.

Authors

R S Accolla¹, P Dellabona, L Scarpellino, G Carra, S Sartoris

Affiliation

¹ Istituto di Scienze Immunologiche, Università di Verona, Policlinico di Borgo Roma, Italy.

PMID: 2406350
DOI: 10.1007/BF02918476

No abstract available

PubMed Disclaimer

Similar articles

Class II transactivator: is it a master switch for MHC class II gene expression?
Chang CH, Roys S, Gourley T. Chang CH, et al. Microbes Infect. 1999 Sep;1(11):879-85. doi: 10.1016/s1286-4579(99)00230-0. Microbes Infect. 1999. PMID: 10614005 Review. No abstract available.
Cell lineage-specific and developmental stage-specific controls of MHC class-II-antigen expression.
Accolla RS, Scupoli MT, Cambiaggi C, Tosi G, Sartoris S. Accolla RS, et al. Int J Cancer Suppl. 1991;6:20-5. doi: 10.1002/ijc.2910470707. Int J Cancer Suppl. 1991. PMID: 1906053 Review.
CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes.
Villard J, Muhlethaler-Mottet A, Bontron S, Mach B, Reith W. Villard J, et al. Int Immunol. 1999 Mar;11(3):461-9. doi: 10.1093/intimm/11.3.461. Int Immunol. 1999. PMID: 10221658
MHC class II transactivator is an in vivo regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunity.
Benasciutti E, Mariani E, Oliva L, Scolari M, Perilli E, Barras E, Milan E, Orfanelli U, Fazzalari NL, Campana L, Capobianco A, Otten L, Particelli F, Acha-Orbea H, Baruffaldi F, Faccio R, Sitia R, Reith W, Cenci S. Benasciutti E, et al. J Bone Miner Res. 2014 Feb;29(2):290-303. doi: 10.1002/jbmr.2090. J Bone Miner Res. 2014. PMID: 24038328
Quantitative control of MHC class II expression by the transactivator CIITA.
Otten LA, Steimle V, Bontron S, Mach B. Otten LA, et al. Eur J Immunol. 1998 Feb;28(2):473-8. doi: 10.1002/(SICI)1521-4141(199802)28:02<473::AID-IMMU473>3.0.CO;2-E. Eur J Immunol. 1998. PMID: 9521055

See all similar articles

Cited by

Evidence for a trans-acting activator function regulating the expression of the human CD5 antigen.
Scupoli MT, Sartoris S, Nicolis M, Cestari T, Cambiaggi C, Tridente G, Accolla RS. Scupoli MT, et al. Immunogenetics. 1994;40(3):217-21. doi: 10.1007/BF00167082. Immunogenetics. 1994. PMID: 7518803
Activation of the HLA-DRA gene in primary human T lymphocytes: novel usage of TATA and the X and Y promoter elements.
Matsushima GK, Itoh-Lindstrom Y, Ting JP. Matsushima GK, et al. Mol Cell Biol. 1992 Dec;12(12):5610-9. doi: 10.1128/mcb.12.12.5610-5619.1992. Mol Cell Biol. 1992. PMID: 1448091 Free PMC article.

References

1. Proc Natl Acad Sci U S A. 1988 Apr;85(7):2229-33 - PubMed
1. Proc Natl Acad Sci U S A. 1984 Aug;81(15):4917-21 - PubMed
1. Immunogenetics. 1982;15(2):139-50 - PubMed
1. J Exp Med. 1986 Jul 1;164(1):369-74 - PubMed
1. Proc Natl Acad Sci U S A. 1987 Jul;84(14):4939-43 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Research Materials
- NCI CPTC Antibody Characterization Program